Your browser doesn't support javascript.
loading
SUMO pathway inhibition targets an aggressive pancreatic cancer subtype.
Biederstädt, Alexander; Hassan, Zonera; Schneeweis, Christian; Schick, Markus; Schneider, Lara; Muckenhuber, Alexander; Hong, Yingfen; Siegers, Gerrit; Nilsson, Lisa; Wirth, Matthias; Dantes, Zahra; Steiger, Katja; Schunck, Kathrin; Langston, Steve; Lenhof, H-P; Coluccio, Andrea; Orben, Felix; Slawska, Jolanta; Scherger, Anna; Saur, Dieter; Müller, Stefan; Rad, Roland; Weichert, Wilko; Nilsson, Jonas; Reichert, Maximilian; Schneider, Günter; Keller, Ulrich.
Afiliación
  • Biederstädt A; Medical Clinic and Policlinic III, Klinikum rechts der Isar, Technical University Munich, München, Germany.
  • Hassan Z; Medical Clinic and Polyclinic II, Klinikum rechts der Isar, Technical University Munich, München, Germany.
  • Schneeweis C; Medical Clinic and Polyclinic II, Klinikum rechts der Isar, Technical University Munich, München, Germany.
  • Schick M; Department of Hematology, Oncology and Tumor Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Schneider L; Center for Bioinformatics, Saarland Informatics Campus, Saarland University, Saarbrücken, Germany.
  • Muckenhuber A; Saarbrücken Graduate School of Computer Science, Saarland Informatics Campus, Saarland University, Saarbrücken, Germany.
  • Hong Y; Institute of Pathology, Technical University Munich, München, Germany.
  • Siegers G; Medical Clinic and Policlinic III, Klinikum rechts der Isar, Technical University Munich, München, Germany.
  • Nilsson L; Medical Clinic and Policlinic III, Klinikum rechts der Isar, Technical University Munich, München, Germany.
  • Wirth M; Department of Surgery, Sahlgrenska Cancer Center, Gothenburg University, Gothenburg, Sweden.
  • Dantes Z; Department of Hematology, Oncology and Tumor Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Steiger K; Medical Clinic and Polyclinic II, Klinikum rechts der Isar, Technical University Munich, München, Germany.
  • Schunck K; Institute of Pathology, Technical University Munich, München, Germany.
  • Langston S; German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Lenhof HP; Goethe University, Medical School, Institute of Biochemistry II, Frankfurt, Germany.
  • Coluccio A; Oncology Drug Discovery Unit, Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA.
  • Orben F; Center for Bioinformatics, Saarland Informatics Campus, Saarland University, Saarbrücken, Germany.
  • Slawska J; Medical Clinic and Polyclinic II, Klinikum rechts der Isar, Technical University Munich, München, Germany.
  • Scherger A; Institute for Translational Cancer Research and Experimental Cancer Therapy, Technical University Munich, München, Germany.
  • Saur D; Medical Clinic and Polyclinic II, Klinikum rechts der Isar, Technical University Munich, München, Germany.
  • Müller S; Medical Clinic and Policlinic III, Klinikum rechts der Isar, Technical University Munich, München, Germany.
  • Rad R; Medical Clinic and Policlinic III, Klinikum rechts der Isar, Technical University Munich, München, Germany.
  • Weichert W; German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Nilsson J; Institute for Translational Cancer Research and Experimental Cancer Therapy, Technical University Munich, München, Germany.
  • Reichert M; Goethe University, Medical School, Institute of Biochemistry II, Frankfurt, Germany.
  • Schneider G; German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Keller U; Institute of Molecular Oncology and Functional Genomics, Technical University Munich, München, Germany.
Gut ; 69(8): 1472-1482, 2020 08.
Article en En | MEDLINE | ID: mdl-32001555
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Proteínas Proto-Oncogénicas c-myc / Carcinoma Ductal Pancreático / Proteínas Modificadoras Pequeñas Relacionadas con Ubiquitina Tipo de estudio: Prognostic_studies Idioma: En Revista: Gut Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Proteínas Proto-Oncogénicas c-myc / Carcinoma Ductal Pancreático / Proteínas Modificadoras Pequeñas Relacionadas con Ubiquitina Tipo de estudio: Prognostic_studies Idioma: En Revista: Gut Año: 2020 Tipo del documento: Article